Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
Ann Intern Med
    September 2021
  1. AL-SAMKARI H, Leaf RK, Goodarzi K
    Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report.
    Ann Intern Med. 2021 Sep 14. doi: 10.7326/L21-0427.
    >> Share

    August 2021
  2. DEEPAK P, Kim W, Paley MA, Yang M, et al
    Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-1757.
    >> Share

  3. CENTOR RM, Klompas M, Pearson M, Morris C, et al
    Annals On Call - The Case for Mandating COVID-19 Vaccines for Health Care Workers.
    Ann Intern Med. 2021 Aug 10:OC1. doi: 10.7326/A20-0020.
    >> Share

    July 2021
  4. EMANUEL EJ, Skorton DJ
    Mandating COVID-19 Vaccination for Health Care Workers.
    Ann Intern Med. 2021 Jul 30. doi: 10.7326/M21-3150.
    >> Share

  5. BUTT AA, Omer SB, Yan P, Shaikh OS, et al
    SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-1577.
    >> Share

  6. KLOMPAS M, Pearson M, Morris C
    The Case for Mandating COVID-19 Vaccines for Health Care Workers.
    Ann Intern Med. 2021 Jul 13. doi: 10.7326/M21-2366.
    >> Share

  7. SACKS HS
    The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at >/=14 d.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    >> Share

    June 2021
  8. SANGLI S, Virani A, Cheronis N, Vannatter B, et al
    Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine.
    Ann Intern Med. 2021 Jun 29. doi: 10.7326/L21-0244.
    >> Share

  9. LAVANGE L, Adam SJ, Currier JS, Higgs ES, et al
    Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.
    Ann Intern Med. 2021 Jun 29. doi: 10.7326/M21-1269.
    >> Share

  10. PISHKO AM, Cuker A
    Thrombosis After Vaccination With Messenger RNA-1273: Is This Vaccine-Induced Thrombosis and Thrombocytopenia or Thrombosis With Thrombocytopenia Syndrome?
    Ann Intern Med. 2021 Jun 29. doi: 10.7326/M21-2680.
    >> Share

  11. THORNTON JD, Dixon-Williams S, Huml A, Perzynski A, et al
    A Cross-Sectional Study of SARS-CoV-2 Vaccination Among Employees of an Urban Safety-Net Health Care System.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/M21-1513.
    >> Share

  12. MATHENY M, Maleque N, Channell N, Eisch AR, et al
    Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/L21-0250.
    >> Share

  13. WERBEL WA, Boyarsky BJ, Ou MT, Massie AB, et al
    Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/L21-0282.
    >> Share

  14. BILINSKI A, Salomon JA, Giardina J, Ciaranello A, et al
    Passing the Test: A Model-Based Analysis of Safe School-Reopening Strategies.
    Ann Intern Med. 2021 Jun 8. doi: 10.7326/M21-0600.
    >> Share

    May 2021
  15. CONNOLLY CM, Boyarsky BJ, Ruddy JA, Werbel WA, et al
    Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M21-1451.
    >> Share

  16. MARION O, Del Bello A, Abravanel F, Couat C, et al
    Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M21-1341.
    >> Share

  17. ARNOLD DT, Milne A, Samms E, Stadon L, et al
    Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M21-1976.
    >> Share

  18. IRFAN N, Chagla Z
    In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant).
    Ann Intern Med. 2021 May 4. doi: 10.7326/ACPJ202105180.
    >> Share

    April 2021

  19. Correction: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.
    Ann Intern Med. 2021 Apr 20. doi: 10.7326/L21-0233.
    >> Share

  20. FOLLMANN D, Fintzi J, Fay MP, Janes HE, et al
    A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
    Ann Intern Med. 2021 Apr 13. doi: 10.7326/M20-8149.
    >> Share

  21. MUSTAFA SS, Ramsey A, Staicu ML
    Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports.
    Ann Intern Med. 2021 Apr 6. doi: 10.7326/L21-0104.
    >> Share

    March 2021
  22. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: Practical Clinical Considerations.
    Ann Intern Med. 2021 Mar 26. doi: 10.7326/M21-1260.
    >> Share

  23. TROGEN B, Caplan A
    Risk Compensation and COVID-19 Vaccines.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/M20-8251.
    >> Share

  24. CHAGLA Z
    In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 >/=14 d after the 2nd dose.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    >> Share

  25. CHAGLA Z
    In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    >> Share

  26. FREEDMAN MS, Bernstein H, Ault KA
    Recommended Adult Immunization Schedule, United States, 2021.
    Ann Intern Med. 2021;174:374-384.
    >> Share

    February 2021
  27. CENTOR RM, Riley LE
    Annals On Call - Pregnancy, Lactation, and the COVID-19 Vaccines.
    Ann Intern Med. 2021 Feb 23:OC1. doi: 10.7326/A20-0009.
    >> Share

  28. SALISCH NC, Stephenson KE, Williams K, Cox F, et al
    A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
    Ann Intern Med. 2021 Feb 16. doi: 10.7326/M20-5306.
    >> Share

  29. OPEL DJ, Lo B, Peek ME
    Addressing Mistrust About COVID-19 Vaccines Among Patients of Color.
    Ann Intern Med. 2021 Feb 9. doi: 10.7326/M21-0055.
    >> Share

  30. GADOTH A, Halbrook M, Martin-Blais R, Gray A, et al
    Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles.
    Ann Intern Med. 2021 Feb 9. doi: 10.7326/M20-7580.
    >> Share

  31. TROTTER AB, Abbott EK, Coyle R, Shen AK, et al
    Preparing for COVID-19 Vaccination: A Call to Action for Clinicians on Immunization Information Systems.
    Ann Intern Med. 2021 Feb 2. doi: 10.7326/M20-7725.
    >> Share

  32. CHAGLA Z
    The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 >/=7 days after the 2nd dose.
    Ann Intern Med. 2021 Feb 2. doi: 10.7326/ACPJ202102160.
    >> Share

    January 2021
  33. RILEY LE, Jamieson DJ
    Inclusion of Pregnant and Lactating Persons in COVID-19 Vaccination Efforts.
    Ann Intern Med. 2021 Jan 26. doi: 10.7326/M21-0173.
    >> Share

  34. FARRIS GE
    Annals Graphic Medicine - Dr. Mom: The Emotions of Getting the COVID-19 Vaccine.
    Ann Intern Med. 2021 Jan 26. doi: 10.7326/G20-0119.
    >> Share

  35. GREGORY JM, Moore DJ
    The Dual Burden of Type 1 Diabetes and COVID-19.
    Ann Intern Med. 2021 Jan 26. doi: 10.7326/M21-0367.
    >> Share

  36. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
    Ann Intern Med. 2021 Jan 25. doi: 10.7326/M21-0331.
    >> Share

  37. CONNORS M, Graham BS, Lane HC, Fauci AS, et al
    SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
    Ann Intern Med. 2021 Jan 19. doi: 10.7326/M21-0111.
    >> Share

  38. CENTOR RM, Manning KD
    Annals On Call - Vaccine Hesitancy: Choosing Our Battles.
    Ann Intern Med. 2021 Jan 19:OC1. doi: 10.7326/A20-0006.
    >> Share

  39. PALTIEL AD, Zheng A, Schwartz JL
    Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-7866.
    >> Share

  40. CARRERA M, Lawler EC, White C
    Population Mortality and Laws Encouraging Influenza Vaccination for Hospital Workers.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-0413.
    >> Share

  41. BARNABAS RV, Wald A
    A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8060.
    >> Share

  42. BOLLYKY TJ
    U.S. COVID-19 Vaccination Challenges Go Beyond Supply.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8280.
    >> Share

  43. TUITE AR, Zhu L, Fisman DN, Salomon JA, et al
    Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8137.
    >> Share

    December 2020
  44. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: Promoting Vaccine Acceptance.
    Ann Intern Med. 2020 Dec 21. doi: 10.7326/M20-8008.
    >> Share

  45. PALMER T, Cuschieri K
    Human Papillomavirus Immunization and the Elimination of Cervical Carcinoma.
    Ann Intern Med. 2020;173:935-936.
    >> Share

    November 2020
  46. CENTOR RM, Goepfert P
    Annals On Call - A Primer on COVID-19 Vaccines.
    Ann Intern Med. 2020 Nov 24:OC1. doi: 10.7326/A19-0044.
    >> Share

  47. MACPHERSON A, Hutchinson N, Schneider O, Oliviero E, et al
    Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.
    Ann Intern Med. 2020 Nov 24. doi: 10.7326/M20-5350.
    >> Share

  48. DAL-RE R, Caplan AL, Gluud C, Porcher R, et al
    Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Ann Intern Med. 2020 Nov 20. doi: 10.7326/M20-7357.
    >> Share

    October 2020
  49. MEHROTRA DV, Janes HE, Fleming TR, Annunziato PW, et al
    Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
    Ann Intern Med. 2020 Oct 22. doi: 10.7326/M20-6169.
    >> Share

  50. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: What Physicians Need to Know.
    Ann Intern Med. 2020 Oct 20. doi: 10.7326/M20-6841.
    >> Share

    September 2020
  51. BAUSSANO I, Tshomo U, Tenet V, Heideman DAM, et al
    Prevalence of Human Papillomavirus and Estimation of Human Papillomavirus Vaccine Effectiveness in Thimphu, Bhutan, in 2011-2012 and 2018 : A Cross-sectional Study.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-2849.
    >> Share

  52. BUTTENHEIM AM
    SARS-CoV-2 Vaccine Acceptance: We May Need to Choose Our Battles.
    Ann Intern Med. 2020 Sep 4. doi: 10.7326/M20-6206.
    >> Share

  53. FISHER KA, Bloomstone SJ, Walder J, Crawford S, et al
    Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults.
    Ann Intern Med. 2020 Sep 4. doi: 10.7326/M20-3569.
    >> Share

  54. HVIID A
    Vaccine Safety in Pregnancy: Going Beyond the Perinatal Period.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-5489.
    >> Share

  55. LUDVIGSSON JF, Winell H, Sandin S, Cnattingius S, et al
    Maternal Influenza A(H1N1) Immunization During Pregnancy and Risk for Autism Spectrum Disorder in Offspring : A Cohort Study.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-0167.
    >> Share

    August 2020
  56. MACINTYRE CR
    Influenza Vaccine: Routine Secondary Prevention for Patients With Cardiovascular Disease?
    Ann Intern Med. 2020 Aug 25. doi: 10.7326/M20-5810.
    >> Share

  57. CHOW EJ, Rolfes MA, O'Halloran A, Anderson EJ, et al
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study.
    Ann Intern Med. 2020 Aug 25. doi: 10.7326/M20-1509.
    >> Share

  58. DONZELLI A
    Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality.
    Ann Intern Med. 2020;173:322.
    >> Share

  59. ANDERSON ML, Dobkin C, Gorry D
    Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality.
    Ann Intern Med. 2020;173:322-323.
    >> Share

    July 2020
  60. TAU N, Yahav D, Shepshelovich D
    Postmarketing Safety of Vaccines Approved by the U.S. Food and Drug Administration: A Cohort Study.
    Ann Intern Med. 2020 Jul 28. doi: 10.7326/M20-2726.
    >> Share

    June 2020
  61. FRYHOFER SA, Fryhofer GW
    Vaccination-Induced Bursitis: Technique Matters.
    Ann Intern Med. 2020 Jun 23. doi: 10.7326/M20-3302.
    >> Share

  62. HESSE EM, Navarro RA, Daley MF, Getahun D, et al
    Risk for Subdeltoid Bursitis After Influenza Vaccination: A Population-Based Cohort Study.
    Ann Intern Med. 2020 Jun 23. doi: 10.7326/M19-3176.
    >> Share

    April 2020
  63. CENTOR RM, Fryhofer SA
    Web Exclusive. Annals On Call - HPV Vaccination 2020.
    Ann Intern Med. 2020;172:OC1.
    >> Share

    March 2020
  64. PLEGUEZUELOS O, Dille J, de Groen S, Oftung F, et al
    Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial.
    Ann Intern Med. 2020 Mar 10. pii: 2762723. doi: 10.7326/M19-0735.
    >> Share

  65. ANDERSON ML, Dobkin C, Gorry D
    The Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality: An Observational Study With a Regression Discontinuity Design.
    Ann Intern Med. 2020 Mar 3. pii: 2762506. doi: 10.7326/M19-3075.
    >> Share

  66. FREEDMAN M, Kroger A, Hunter P, Ault KA, et al
    Recommended Adult Immunization Schedule, United States, 2020.
    Ann Intern Med. 2020;172:337-347.
    >> Share

    February 2020
  67. ALDOSS I, La Rosa C, Baden LR, Longmate J, et al
    Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.
    Ann Intern Med. 2020 Feb 11. pii: 2760880. doi: 10.7326/M19-2511.
    >> Share

    December 2019
  68. LAPRISE JF, Chesson HW, Markowitz LE, Drolet M, et al
    Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States.
    Ann Intern Med. 2019 Dec 10. pii: 2757403. doi: 10.7326/M19-1182.
    >> Share

    November 2019
  69. MELLO MM
    Narrowing Vaccination Exemption Laws: Lessons From California and Beyond.
    Ann Intern Med. 2019 Nov 5. pii: 2754178. doi: 10.7326/M19-3111.
    >> Share

  70. DELAMATER PL, Buttenheim AM, Klein NP, Mohanty S, et al
    Assessment of Exemptions From Vaccination in California, 2015 to 2027.
    Ann Intern Med. 2019 Nov 5. pii: 2754177. doi: 10.7326/M19-1933.
    >> Share

    September 2019
  71. HVIID A, Hansen JV, Frisch M, Melbye M, et al
    Measles, Mumps, Rubella Vaccination and Autism.
    Ann Intern Med. 2019;171:388.
    >> Share

  72. MAWSON AR
    Measles, Mumps, Rubella Vaccination and Autism.
    Ann Intern Med. 2019;171:386-387.
    >> Share

  73. CROSBY J
    Measles, Mumps, Rubella Vaccination and Autism.
    Ann Intern Med. 2019;171:387-388.
    >> Share

    July 2019
  74. WILDER-SMITH A, Barrett A, Vannice K, Hombach J, et al
    Long-Term Protection After Fractional-Dose Yellow Fever Vaccination.
    Ann Intern Med. 2019;171:145-146.
    >> Share

    March 2019

  75. The MMR Vaccine Is Not Associated With Risk for Autism.
    Ann Intern Med. 2019 Mar 5. pii: 2727209. doi: 10.7326/P19-0002.
    >> Share

  76. HVIID A, Hansen JV, Frisch M, Melbye M, et al
    Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study.
    Ann Intern Med. 2019 Mar 5. pii: 2727726. doi: 10.7326/M18-2101.
    >> Share

  77. OMER SB, Yildirim I
    Further Evidence of MMR Vaccine Safety: Scientific and Communications Considerations.
    Ann Intern Med. 2019 Mar 5. pii: 2727208. doi: 10.7326/M19-0596.
    >> Share

    February 2019
  78. SACKS HS
    Review: Adjuvant recombinant subunit vaccine prevents herpes zoster more than live attenuated vaccine in adults >/= 50 years.
    Ann Intern Med. 2019;170:JC14.
    >> Share

  79. SHAFRAN SD
    Prevention of Shingles: Better Protection and Better Value With Recombinant Vaccine.
    Ann Intern Med. 2019 Feb 19. pii: 2725148. doi: 10.7326/M19-0141.
    >> Share

  80. PROSSER LA, Harpaz R, Rose AM, Gebremariam A, et al
    A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations.
    Ann Intern Med. 2019 Feb 19. pii: 2725147. doi: 10.7326/M18-2347.
    >> Share

    November 2018
  81. ROUKENS AHE, van Halem K, de Visser AW, Visser LG, et al
    Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial.
    Ann Intern Med. 2018 Nov 27. pii: 2716699. doi: 10.7326/M18-1529.
    >> Share

    June 2018
  82. ABARA WE, Qaseem A, Schillie S, McMahon BJ, et al
    Hepatitis B Vaccination, Screening, and Linkage to Care.
    Ann Intern Med. 2018;168:902-903.
    >> Share

  83. LOWE DM
    Hepatitis B Vaccination, Screening, and Linkage to Care.
    Ann Intern Med. 2018;168:901-902.
    >> Share

  84. ALPERN JD, Leventhal TM, Bahr NC
    Hepatitis B Vaccination, Screening, and Linkage to Care.
    Ann Intern Med. 2018;168:902.
    >> Share

    April 2018
  85. DURHAM DP, Fitzpatrick MC, Ndeffo-Mbah ML, Parpia AS, et al
    Evaluating Vaccination Strategies for Zika Virus in the Americas.
    Ann Intern Med. 2018 Apr 3. pii: 2677349. doi: 10.7326/M17-0641.
    >> Share

    December 2017
  86. WEISER J, Perez A, Bradley H, King H, et al
    Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012.
    Ann Intern Med. 2017 Dec 26. pii: 2667091. doi: 10.7326/M17-1689.
    >> Share

    November 2017
  87. ABARA WE, Qaseem A, Schillie S, McMahon BJ, et al
    Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention.
    Ann Intern Med. 2017 Nov 21. doi: 10.7326/M17-1106.
    >> Share


  88. Hepatitis B Vaccination, Screening, and Linkage to Care.
    Ann Intern Med. 2017 Nov 21. doi: 10.7326/P17-9048.
    >> Share

    September 2017
  89. LUCEY DR, Donaldson H
    Yellow Fever Vaccine Shortages in the United States and Abroad: A Critical Issue.
    Ann Intern Med. 2017 Sep 26. doi: 10.7326/M17-1337.
    >> Share

    April 2017
  90. TALAL AH, Thomas DL, Reynolds JL, Khalsa JH, et al
    Toward Optimal Control of Hepatitis C Virus Infection in Persons With Substance Use Disorders.
    Ann Intern Med. 2017 Apr 25. doi: 10.7326/M16-2887.
    >> Share

  91. BUCKLEY GJ, Strom BL
    A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis C.
    Ann Intern Med. 2017 Apr 4. doi: 10.7326/M17-0766.
    >> Share

    April 2016
  92. BUCKLEY GJ, Strom BL
    What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States?
    Ann Intern Med. 2016 Apr 12. doi: 10.7326/M16-0772.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016